234 related articles for article (PubMed ID: 20848680)
1. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Gelber AC
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
[No Abstract] [Full Text] [Related]
2. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Herrlinger KR; Stange EF
N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
[No Abstract] [Full Text] [Related]
3. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Ruffolo C; Scarpa M; Bassi N
N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
[No Abstract] [Full Text] [Related]
4. Infliximab, azathioprine, or combination therapy for Crohn's disease.
Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens G; Diamond RH; Broussard DL; Tang KL; van der Woude CJ; Rutgeerts P;
N Engl J Med; 2010 Apr; 362(15):1383-95. PubMed ID: 20393175
[TBL] [Abstract][Full Text] [Related]
5. [New therapeutic option for M. Crohn : SONIC study (study of biologic and immunomodulator naive patients in Crohn's disease)].
Fölsch UR; Nitschmann S
Internist (Berl); 2010 Sep; 51(9):1202-4. PubMed ID: 20658120
[No Abstract] [Full Text] [Related]
6. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
7. Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.
van den Brande JM; Peppelenbosch MP; Hommes DW
Gastroenterology; 2006 Oct; 131(4):1362-3. PubMed ID: 17030216
[No Abstract] [Full Text] [Related]
8. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
Sorrentino D; Paviotti A
Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
[No Abstract] [Full Text] [Related]
9. Infliximab treatment induces levels of the active azathioprine metabolite TGTP in Crohn's disease.
Teichgräber U; Atreya I; Atreya R; Schwab M; Neurath MF
Inflamm Bowel Dis; 2013; 19(4):E54-5. PubMed ID: 22532373
[No Abstract] [Full Text] [Related]
10. Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
Ferkolj I; Hocevar A; Golouh R; Dolenc Voljc M
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Dec; 15(4):173-7. PubMed ID: 17982610
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of Pyoderma gangrenosum associated with Crohn's disease.
Zaccagna A; Bertone A; Puiatti P; Picciotto F; Sprujevnik T; Santucci R; Rossini FP
Eur J Dermatol; 2003; 13(3):258-60. PubMed ID: 12804985
[TBL] [Abstract][Full Text] [Related]
12. Infliximab therapy in a patient with refractory ileocolic Crohn's disease and Takayasu arteritis.
Calderón R; Estrada S; Ramírez de la Piscina P; Salvador M; Zabaleta S; Enciso C; Delgado E; García-Campos F
Rev Esp Enferm Dig; 2010 Feb; 102(2):145-6. PubMed ID: 20361852
[No Abstract] [Full Text] [Related]
13. Infliximab and azathioprine: bridge or parachute?
Travis S
Gastroenterology; 2006 Apr; 130(4):1354-7. PubMed ID: 16618428
[No Abstract] [Full Text] [Related]
14. [Biological therapy as treatment of inflammatory bowel diseases].
Agnholt J
Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
[TBL] [Abstract][Full Text] [Related]
15. [New therapy in inflammatory bowel disease (infliximab)].
Yoshizawa S; Hibi T
Nihon Rinsho; 2008 Jul; 66(7):1279-85. PubMed ID: 18616118
[TBL] [Abstract][Full Text] [Related]
16. [Top-down versus Step-Up: new strategies in the treatment of Crohn's disease].
Meier J; Sturm A
Z Gastroenterol; 2009 Feb; 47(2):240-2. PubMed ID: 19197829
[No Abstract] [Full Text] [Related]
17. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Bischoff A
MMW Fortschr Med; 2010 Jan; 152(1-2):20. PubMed ID: 20302159
[No Abstract] [Full Text] [Related]
19. Is there a role for multidrug therapy in active Crohn's disease?
Forbes A
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S257-8. PubMed ID: 18816649
[No Abstract] [Full Text] [Related]
20. [CED therapy with infliximab. Rapid and lasting remission - complete mucosal healing].
Wedekind S
MMW Fortschr Med; 2011 Dec; 153(48):54-5. PubMed ID: 22299262
[No Abstract] [Full Text] [Related]
[Next] [New Search]